Cadernos de Pesquisa Do UNIFAA · Oct 30, 2026
Musculoskeletal syndrome of menopause
By de Souza MCA, de Souza PM
INTRODUCTION: Musculoskeletal syndrome of menopause (SMM) encompasses musculoskeletal manifestations resulting from ovarian failure, such as arthralgia, sarcopenia, stiffness, muscle weakness, and loss of bone mineral density, promoting the progression of osteoarthritis. OBJECTIVE: To review the literature on SMM, its prevalent symptoms, and its impacts on women's quality of life. MATERIALS AND METHODS: This is a narrative literature review, with searches of the SciELO and PubMed/MEDLINE electronic databases for studies published between 2020 and 2026. Controlled descriptors were used. Literature review articles and official documents were included. RESULTS: After applying the inclusion criteria, 17 studies were selected for analysis and interpretation. DISCUSSION: SMM is a chronic and progressive condition, increasing the risk of falls, frailty, and mortality. Early diagnosis is challenging, as cases with no visible changes on imaging examinations have been reported, leading to the minimization of symptoms, often attributed to natural aging, delaying treatment. Addressing the condition requires early screening, encouragement of muscle-strengthening exercises, use of medications, and also timely access to hormone replacement therapy, when indicated. CONCLUSIONS: SMM compromises quality of life and can progress to outcomes that, however, can be mitigated by appropriate hormone replacement and clinical management. Given the increase in female longevity, it is essential to disseminate knowledge about SMM to train professionals in diagnosis and appropriate treatment.